Enzolytics Inc
Change company Symbol lookup
Select an option...
ENZC Enzolytics Inc
GREE Greenidge Generation Holdings Inc
MLM Martin Marietta Materials Inc
ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027
NRAC Noble Rock Acquisition Corp
DCGO DocGo Inc
VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028
MRC MRC Global Inc
BAC Bank of America Corp
BKR Baker Hughes Co
Go

Company profile

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

Closing Price
$0.0737
Day's Change
0.0027 (3.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0821
Day's Low
0.0701
Volume
(Light)
Volume:
5,325,554

10-day average volume:
9,319,420
5,325,554

Dollar Tree Inc. Stock Outperforms Competitors Despite Losses On The Day

4:30 pm ET January 12, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Dollar Tree Inc. (DLTR) slumped 0.15% to $136.90 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.28% to 4,726.35 and the Dow Jones Industrial Average rising 0.11% to 36,290.32. Dollar Tree Inc. closed $12.47 short of its 52-week high ($149.37), which the company reached on November 24th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Target Corp. (TGT) fell 1.35% to $224.47, Dollar General Corp. (DG) fell 0.02% to $228.60, and Wal-Mart de Mexico S.A.B. de C.V. ADR (WALMEX.MX) rose 0.71% to $35.70. Trading volume (3.2 M) remained 551,739 below its 50-day average volume of 3.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 12, 2022.

-MarketWatch Automation

	

(END) Dow Jones Newswires

January 12, 2022 16:30 ET (21:30 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.